Literature DB >> 16934070

Outliers in RhD membrane integration are explained by variant RH haplotypes.

Xinjian Yu1, Franz F Wagner, Bernd Witter, Willy A Flegel.   

Abstract

BACKGROUND: Variations in a multipass transmembrane protein may affect its membrane integration. To study this effect, the systematic molecular characterization of variant D antigen density is a suitable model. Unlike most other membrane proteins, the expression of the D antigen is often determined by a single allele, because it occurs frequently in hemizygous form. STUDY DESIGN AND METHODS: The D antigen density distribution of 530 CcDee, 475 ccDEe, and 514 ccDee random samples was established by flow cytometry. The molecular bases of samples with D antigen densities outside a bell-shaped peak was investigated.
RESULTS: The antigen densities of 499 CcDee, 437 ccDEe, and 480 ccDee samples formed bell-shaped peaks. Three, 10, and 12 samples, respectively, had decreased antigen densities and carried variant RHD alleles. Weak D type 19, RHD(I204T); weak D type 20, RHD(F417S); and the partial D DYU (also known as DQC), RHD(R234W) were new RHD alleles. Twenty-eight CcDee, 28 ccDEe, and 22 ccDee samples had increased antigen densities; 53 of them lacked a hybrid Rhesus box and were thus predicted to be RHD homozygous. Eight ccDee samples were predicted to be heterozygous despite a large relative dose of RHD to RHCE alleles in quantitative polymerase chain reaction. One of these samples was further investigated and carried an RHD-CE hybrid transcript characteristic for a -D- haplotype.
CONCLUSIONS: Unusual little and large RhD protein integration into the membrane could be traced to a host of distinct protein variants. Weak expression of D antigen was invariably associated with variant RHD alleles. Larger than normal D antigen density may often be caused by the presence of two D encoding alleles, which may be located in cis, and confounding zygosity testing that is solely based on gene copy number.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934070     DOI: 10.1111/j.1537-2995.2006.00902.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Authors:  Willy A Flegel; Thierry Peyrard; Jacques Chiaroni; Christophe Tournamille; Déborah Jamet; France Pirenne
Journal:  Blood Transfus       Date:  2018-05-03       Impact factor: 3.443

3.  A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.

Authors:  Patrick T McGann; Jenny M Despotovic; Thad A Howard; Russell E Ware
Journal:  Am J Hematol       Date:  2011-11-25       Impact factor: 10.047

4.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

5.  What constitutes the most cautious approach for a pregnant person with weak D type 4.0?

Authors:  Willy Albert Flegel; Melanie Bodnar; Gwen Clarke; Judith Hannon; Lani Lieberman
Journal:  CMAJ       Date:  2021-06-14       Impact factor: 8.262

6.  Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans.

Authors:  K Srivastava; M U Bueno; W A Flegel
Journal:  Immunohematology       Date:  2022-04-29

7.  Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.

Authors:  Ann Reed Gaines; Hallie Lee-Stroka; Karen Byrne; Dorothy E Scott; Lynne Uhl; Ellen Lazarus; David F Stroncek
Journal:  Transfusion       Date:  2009-02-09       Impact factor: 3.157

8.  D category IV: a group of clinically relevant and phylogenetically diverse partial D.

Authors:  Inge von Zabern; Franz F Wagner; Joann M Moulds; John J Moulds; Willy A Flegel
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

9.  Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.

Authors:  Mouna Ouchari; Kshitij Srivastava; Houda Romdhane; Saloua Jemni Yacoub; Willy Albert Flegel
Journal:  Transfusion       Date:  2017-11-29       Impact factor: 3.157

10.  Evolutionary genetics of the human Rh blood group system.

Authors:  George H Perry; Yali Xue; Richard S Smith; Wynn K Meyer; Minal Calışkan; Omar Yanez-Cuna; Arthur S Lee; María Gutiérrez-Arcelus; Carole Ober; Edward J Hollox; Chris Tyler-Smith; Charles Lee
Journal:  Hum Genet       Date:  2012-02-25       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.